British regulators on Thursday said they have identified 30 cases of rare blood clot events after the use of the AstraZeneca COVID-19 vaccine, 25 more than the agency previously reported.
The Medicines and Healthcare products Regulatory Agency (MHRA) said it had received no such reports of clotting events following use of the vaccine made by BioNTech SE and Pfizer Inc.
On Friday, the medicine regulator told the Financial Times and The Guardian that seven recipients of the AstraZeneca vaccine have died after registering the rare blood clotting events. Reuters was not immediately able to confirm the figure from MHRA after office hours.
MHRA, European Medicines Agency and the W…
Keep on reading: UK regulator found total of 30 cases of blood clot events after AstraZeneca vaccine use